Privia Health Group Inc [PRVA] stock is trading at $19.07, up 1.44%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PRVA shares have gain 4.44% over the last week, with a monthly amount drifted -5.36%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Privia Health Group Inc [NASDAQ: PRVA] stock has seen the most recent analyst activity on May 30, 2024, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $23. Previously, Citigroup started tracking the stock with Buy rating on April 22, 2024, and set its price target to $25. On March 06, 2024, Barclays initiated with a Equal Weight rating and assigned a price target of $22 on the stock. BofA Securities downgraded its rating to a Neutral but $21 remained the price target by the analyst firm on February 22, 2024. JMP Securities started tracking with a Mkt Outperform rating for this stock on December 06, 2023, and assigned it a price target of $27. In a note dated June 13, 2023, Evercore ISI initiated an Outperform rating and provided a target price of $34 on this stock.
Privia Health Group Inc [PRVA] stock has fluctuated between $15.92 and $24.35 over the past year. Currently, Wall Street analysts expect the stock to reach $33.82 within the next 12 months. Privia Health Group Inc [NASDAQ: PRVA] shares were valued at $19.07 at the most recent close of the market. An investor can expect a potential return of 77.35% based on the average PRVA price forecast.
Analyzing the PRVA fundamentals
Privia Health Group Inc [NASDAQ:PRVA] reported sales of 1.70B for the trailing twelve months, which represents a growth of 2.17%. Gross Profit Margin for this corporation currently stands at 0.09% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.39 points at the first support level, and at 17.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.88, and for the 2nd resistance point, it is at 20.69.
Ratios To Look Out For
For context, Privia Health Group Inc’s Current Ratio is 1.81. Further, the Quick Ratio stands at 1.81, while the Cash Ratio is 0.9. Considering the valuation of this stock, the price to sales ratio is 1.34, the price to book ratio is 3.83 and price to earnings (TTM) ratio is 159.72.
Transactions by insiders
Recent insider trading involved Mehrotra Parth, Chief Executive Officer, that happened on Sep 10 ’24 when 0.14 million shares were sold. Officer, Mehrotra Parth completed a deal on Sep 10 ’24 to buy 0.14 million shares. Meanwhile, Director Boehler Adam bought 364.0 shares on Jun 11 ’24.
